EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The combination of mupirocin and Kayvirus broadens the decolonization effect against Staphylococcus aureus

Alena Siváková, Eliška Figallová, Tibor Botka, Lukáš Vacek, Jan Tkadlec, Jan Vrbský, Martin Osowski, Petr Petráš, Dominika Polaštík Kleknerová, Milada Dvořáčková, Pavlína Urbanová, Roman Pantůček und 1 weitere

Applied Microbiology and Biotechnology · 16.04.2026 · 110 (1)

DOI: 10.1007/s00253-026-13814-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 16.04.2026. Verfasst von Alena Siváková und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic. Hauptthemen laut MEDLINE: Mupirocin, Staphylococcus aureus, Staphylococcus Phages, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Masarykova Univerzita, Ministerstvo Zdravotnictví Ceské Republiky, Masaryk University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sta phy loc occus aureus strains cause a wide range of infections in humans, often with the potential for complications such as surgical site infections. The production of Panton-Valentin leukocidin (PVL) by certain strains of S. aureus is clinically associated with chronic or recurrent infections, which typically require decolonization, most often with mupirocin. As increased mupirocin use promotes the emergence of resistance, this study investigated the coadministration of mupirocin and therapeutic Kayvirus bacteriophage as a potential strategy to enhance treatment efficacy and prevent the development of new resistance. We collected and evaluated 37 PVL-encoding S. aureus strains from wound samples. Among these, 22% were methicillin-resistant, and 11% were resistant to the tested phage, but all were susceptible to mupirocin. To assess interactions between mupirocin and the phage in PVL-positive strains with varying levels of mupirocin resistance, we used lysogenization by PVL-encoding phage and adaptive laboratory evolution of clinical strains. In mupirocin-susceptible strains, lytic phage efficacy decreased due to altered protein synthesis caused by the interaction of mupirocin with isoleucyl-tRNA synthetase, whereas mupirocin efficacy was unaffected. In contrast, the advantage of combined administration was observed in mupirocin-resistant strains susceptible to phages, as their altered or alternative synthetase allowed protein synthesis to continue, enabling phage proliferation and bacterial lysis, even in the presence of mupirocin. This in vitro study demonstrates that mupirocin in combination with Kayvirus broadens the spectrum of strains susceptible to treatment and that the phage used prevents the development of mupirocin resistance. Key points • Mupirocin-phage combination broadens the anti-staphylococcal effect in vitro. • Combination treatment reduces the emergence of mupirocin resistance. • Mupirocin action is not inhibited by phage therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MupirocinStaphylococcus aureusStaphylococcus PhagesAnti-Bacterial AgentsStaphylococcal InfectionsHumansLeukocidinsBacterial ToxinsExotoxinsIsoleucine-tRNA LigaseDrug Resistance, BacterialLysogeny

Stichwörter der Autor:innen

KayvirusStaphylococcus aureusDecolonizationMupirocinPanton-Valentine leukocidinPhage therapy

Substanzen

MupirocinAnti-Bacterial AgentsLeukocidinsPanton-Valentine leukocidinBacterial ToxinsExotoxinsIsoleucine-tRNA Ligase

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic.
  • Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. tibor.botka@mail.muni.cz.
  • Department of Medical Microbiology, Second Faculty of Medicine, Charles University and University Hospital Motol and Homolka, Prague, Czech Republic.
  • National Reference Laboratory for Staphylococci, National Institute of Public Health, Prague, Czech Republic.

Förderung

  • Masarykova Univerzita
  • Ministerstvo Zdravotnictví Ceské Republiky
  • Masaryk University

Zitieren

APA

Siváková, A., Figallová, E., Botka, T., Vacek, L., Tkadlec, J., Vrbský, J., Osowski, M., Petráš, P., Polaštík Kleknerová, D., Dvořáčková, M., Urbanová, P., Pantůček, R., & Růžička, F. (2026). The combination of mupirocin and Kayvirus broadens the decolonization effect against Staphylococcus aureus. Applied Microbiology and Biotechnology, 110(1). https://doi.org/10.1007/s00253-026-13814-0

Vancouver

Siváková A, Figallová E, Botka T, Vacek L, Tkadlec J, Vrbský J, et al. The combination of mupirocin and Kayvirus broadens the decolonization effect against Staphylococcus aureus. Applied Microbiology and Biotechnology. 2026;110(1). doi:10.1007/s00253-026-13814-0

BibTeX
@article{Sivkov2026,
  author = {Siváková, Alena and Figallová, Eliška and Botka, Tibor and Vacek, Lukáš and Tkadlec, Jan and Vrbský, Jan and Osowski, Martin and Petráš, Petr and Polaštík Kleknerová, Dominika and Dvořáčková, Milada and Urbanová, Pavlína and Pantůček, Roman and Růžička, Filip},
  title = {The combination of mupirocin and Kayvirus broadens the decolonization effect against Staphylococcus aureus},
  journal = {Applied Microbiology and Biotechnology},
  year = {2026},
  volume = {110},
  number = {1},
  doi = {10.1007/s00253-026-13814-0}
}
Kostenlos starten →